MedTrace Logo

Clinical Performance Evaluation of DxN HCV Assay

NCT03125408 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2018-07-12

No results posted yet for this study

Summary

The DxN Hepatitis C Virus (HCV) Assay is an in vitro diagnostic assay intended as an aid in the management of of HCV-infected individuals undergoing antiviral therapy. The purpose of the study is to establish the clinical performance of the DxN HCV Assay for plasma samples in the intended use population.

Conditions

  • Hepatitis C

Interventions

DIAGNOSTIC_TEST

HCV Assay

Molecular diagnostic test to detect Hepatitus C

Sponsors & Collaborators

  • Beckman Coulter, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-02
Primary Completion
2017-08-30
Completion
2017-08-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03125408 on ClinicalTrials.gov